𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical risk management of herb–drug interactions

✍ Scribed by Peter A. G. M. De Smet

Book ID
108641740
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
112 KB
Volume
63
Category
Article
ISSN
0306-5251

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Psychotropic drug metabolism in the canc
Psychotropic drug metabolism in the cancer patient: clinical aspects of management of potential drug interactions
✍ Glenn R. Kalash 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

An overview of drug metabolism, with particular focus on the cytochrome p450 system, is provided in this review. To date, there has been a growing body of literature concerning the cytochrome p450 enzyme, drug -drug interactions and the role of psychotropic medications when co-administered with medi

Drug–herb interactions: unexpected suppr
Drug–herb interactions: unexpected suppression of free Danshen concentrations by salicylate
✍ Deepali Gupta; Mehri Jalali; Alice Wells; Amitava Dasgupta 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract The general population of the U.S. uses over‐the‐counter herbal medicines. Danshen is a Chinese herbal product used for the treatment of cardiovascular disease. In a previous study we showed that Danshen has significant digoxin‐like immunoreactivity, and we used this parameter to monito

In vivo assessment of herb–drug interact
In vivo assessment of herb–drug interactions: Possible utility of a pharmacogenetic approach?
✍ Brian Tomlinson; Miao Hu; Vivian W. Y. Lee 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract Herbal medicines are frequently used in combination with conventional drugs and interactions are likely to be more common than those which manifest clinically. Pharmacokinetic interactions mediated by drug‐metabolizing enzymes or transporters are involved in many herb–drug interactions.